In vitro activities of natural products against oral Candida isolates from denture wearers

BMC Complementary and Alternative Medicine

Volumn 11, Issue , 2011, Pages

  Marcos Arias, Cristina ^a   Eraso, Elena ^a   Madariaga, Lucila ^a   Quindós, Guillermo ^a  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; CARVACROL; ESSENTIAL OIL; EUGENOL; FARNESOL; FLUCONAZOLE; GERANIOL; LINALOOL; MENTHOL; MENTHONE; TERPENE DERIVATIVE; TERPINEN 4 OL; TERPINEOL; TYROSOL; BIOLOGICAL PRODUCT;

ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDA; CANDIDA ALBICANS; CANDIDA DUBLINIENSIS; CANDIDA GLABRATA; CANDIDA KRUSEI; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; CONTROLLED STUDY; DENTURE; FUNGAL STRAIN; FUNGUS GROWTH; FUNGUS ISOLATION; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PICHIA GUILLIERMONDII; DENTAL SURGERY; DRUG EFFECT; HUMAN; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; STOMATITIS; THRUSH;

ANTIFUNGAL AGENTS; BIOLOGICAL AGENTS; CANDIDA; CANDIDIASIS, ORAL; DENTAL RESTORATION WEAR; HUMANS; MICROBIAL SENSITIVITY TESTS; OILS, VOLATILE; STOMATITIS, DENTURE;

EID: 82055171731     PISSN: None     EISSN: 14726882     Source Type: Journal    
DOI: 10.1186/1472-6882-11-119     Document Type: Article

References (29)

1. Gendreau L, Loewy ZG. Epidemiology and etiology of denture stomatitis. J Prosthodont 2011, 20:251-260. 10.1111/j.1532-849X.2011.00698.x, 21463383.
2. Marcos-Arias C, Vicente JL, Sahand IH, Eguía A, De-Juan A, Madariaga L, Aguirre JM, Eraso E, Quindós G. Isolation of Candida dubliniensis in denture stomatitis. Arch Oral Biol 2009, 54:127-131. 10.1016/j.archoralbio.2008.09.005, 18950745.
3. Samaranayake LP, Leung WK, Jin L. Oral mucosal fungal infections. Periodontology 2000 2009, 49:39-59. 10.1111/j.1600-0757.2008.00291.x, 19152525.
4. Webb BC, Thomas CJ, Willcox MD, Harty DW, Knox KW. Candida-associated denture stomatitis. Aetiology and management: a review. Part 1. Factors influencing distribution of Candida species in the oral cavity. Aust Dent J 1998, 43:45-50. 10.1111/j.1834-7819.1998.tb00152.x, 9583226.
5. Webb BC, Thomas CJ, Willcox MD, Harty DW, Knox KW. Candida-associated denture stomatitis. Aetiology and management: a review. Part 3. Treatment of oral candidosis. Aust Dent J 1998, 43:244-249. 10.1111/j.1834-7819.1998.tb00172.x, 9775471.
6. Barchiesi F, Silvestri C, Arzeni D, Ganzetti G, Castelletti S, Simonetti O, Cirioni O, Kamysz W, Kamysz E, Spreghini E, Abruzzetti A, Riva A, Offidani AM, Giacometti A, Scalise G. In vitro susceptibility of dermatophytes to conventional and alternative antifungal agents. Med Mycol 2009, 47:321-326. 10.1080/13693780802641920, 19115137.
7. Hammer KA, Carson CF, Riley TV. Melaleuca alternifolia (tea tree) oil inhibits germ tube formation by Candida albicans. Med Mycol 2000, 38:355-362.
8. Palmeira de Oliveira A, Salgueiro L, Palmeira de Oliveira R, Martinez de Oliveira J, Pina Vaz C, Queiroz JA, Rodrigues AG. Anti-Candida activity of essential oils. Mini-Reviews in Medicinal Chemistry 2009, 9:1292-1305. 10.2174/138955709789878150, 19534688.
9. Pauli A. Anticandidal low molecular compounds from higher plants with special reference to compounds from essential oils. Med Res Rev 2006, 26:223-268. 10.1002/med.20050, 16331694.
10. Eraso E, Moragues MD, Villar-Vidal M, Sahand IH, González-Gómez N, Pontón J, Quindós G. Evaluation of the new chromogenic medium Candida ID 2 for isolation and identification of Candida albicans and other medically important Candida species. J Clin Microbiol 2006, 44:3340-3345. 10.1128/JCM.00213-06, 1594741, 16954270.
11. Dalleau S, Cateau E, Bergès T, Berjeaud JM, Imbert C. In vitro activity of terpenes against Candida biofilms. Int J Antimicrob Agents 2008, 31:572-576. 10.1016/j.ijantimicag.2008.01.028, 18440786.
12. Clinical and Laboratory Standards Institute Reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard 2010, CLSI, Wayne, PA, USA, 3, CLSI document M27-A3 and Supplement S3, Clinical and Laboratory Standards Institute.
13. Cantón E, Pemán J, Viudes A, Quindós G, Gobernado M, Espinel-Ingroff A. Minimum fungicidal concentrations of amphotericin B for bloodstream Candida species. Diagn Microbiol Infect Dis 2003, 45:203-206. 10.1016/S0732-8893(02)00525-4, 12663162.
14. Bakkali F, Averbeck S, Averbeck D, Idaomar M. Biological effects of essential oils-a review. Food Chem Toxicol 2008, 46:446-475. 10.1016/j.fct.2007.09.106, 17996351.
15. Braga PC, Culici M, Alfieri M, Dal Sasso M. Thymol inhibits Candida albicans biofilm formation and mature biofilm. Int J Antimicrob Agents 2008, 31:472-477. 10.1016/j.ijantimicag.2007.12.013, 18329858.
16. Tampieri MP, Galuppi R, Macchioni F, Carelle MS, Falcioni L, Cioni PL, Morelli I. The inhibition of Candida albicans by selected essential oils and their major components. Mycopathologia 2005, 159:339-345. 10.1007/s11046-003-4790-5, 15883716.
17. Cox SD, Mann CM, Markham JL, Bell HC, Gustafson JE, Warmington JR, Wyllie SG. The mode of antimicrobial action of the essential oil of Melaleuca alternifolia (tea tree oil). J Appl Microbiol 2000, 88:170-175.
18. Ahmad A, Khan A, Akhtar F, Yousuf S, Xess I, Khan LA, Manzoor N. Fungicidal activity of thymol and carvacrol by disrupting ergosterol biosynthesis and membrane integrity against Candida. Eur J Clin Microbiol Infect Dis 2011, 30:41-50. 10.1007/s10096-010-1050-8, 20835742.
19. Alem MA, Oteef MD, Flowers TH, Douglas LJ. Production of tyrosol by Candida albicans biofilms and its role in quorum sensing and biofilm development. Eukaryot Cell 2006, 5:1770-1779. 10.1128/EC.00219-06, 1595342, 16980403.
20. Ramage G, Saville SP, Wickes BL, López-Ribot JL. Inhibition of Candida albicans biofilm formation by farnesol, a quorum-sensing molecule. Appl Environ Microbiol 2002, 68:5459-5463. 10.1128/AEM.68.11.5459-5463.2002, 129887, 12406738.
21. He M, Du M, Fan M, Bian Z. In vitro activity of eugenol against Candida albicans biofilms. Mycopathologia 2007, 163:137-143. 10.1007/s11046-007-0097-2, 17356790.
22. Oliva B, Piccirilli E, Ceddia T, Pontieri E, Aureli P, Ferrini AM. Antimycotic activity of Melaleuca alternifolia essential oil and its major components. Lett Appl Microbiol 2003, 37:185-187. 10.1046/j.1472-765X.2003.01375.x, 12859665.
23. Traboulsi RS, Mukherjee PK, Ghannouma MA. In vitro activity of inexpensive topical alternatives against Candida spp. isolated from the oral cavity of HIV-infected patients. Int J Antimicrob Agents 2008, 31:272-276. 10.1016/j.ijantimicag.2007.11.008, 18242063.
24. Chami F, Chami N, Bennis S, Trouillas J, Remmal A. Evaluation of carvacrol and eugenol as prophylaxis and treatment of vaginal candidiasis in an immunosuppressed rat model. J Antimicrob Chemother 2004, 54:909-914. 10.1093/jac/dkh436, 15456732.
25. Ahmad A, Khan A, Khan LA, Manzoor N. In vitro synergy of eugenol and methyleugenol with fluconazole against clinical Candida isolates. J Med Microbiol 2010, 59:1178-1184. 10.1099/jmm.0.020693-0, 20634332.
26. Chao SC, Young DG, Oberg CJ. Screening for inhibitory activity of essential oils on selected bacteria, fungi and viruses. J Essential Oil Res 2000, 12:639-649.
27. Concha JM, Moore LS, Holloway WJ. Antifungal activity of Melaleuca alternifolia (tea-tree) oil against various pathogenic organisms. J Am Podiatr Med Assoc 1988, 88:489-492.
28. Mondello F, De Bernardis F, Girolamo A, Cassone A, Salvatore G. In vivo activity of terpinen-4-ol. The main bioactive component of Malaleuca alternifolia Cheel (tea tree) oil against azole-susceptible and -resistant human pathogenic Candida species. BMC Infect Dis 2006, 6:158. 10.1186/1471-2334-6-158, 1637110, 17083732.
29. Hammer KA, Carson CF, Riley TV, Nielsen J. A review of the toxicity of Melaleuca alternifolia (tea-tree oil). Food Chem Toxicol 2006, 44:616-625. 10.1016/j.fct.2005.09.001, 16243420.